Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
house id
legislature	pref label
question text
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

746105

registered interest
date	28/06/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
house id	2
legislature	25277 pref label House of Lords
question text	Her Majesty's Government what is their latest estimate of the number of nursing posts vacant within the NHS in England.
tabling member printed	Lord Wigley
uin	HL247
answer	answer is ministerial correction date of answer 12/07/2017 answer text <p>The information is not available in the format requested.</p><p> </p><p>Health Education England (HEE) provide estimates of staff shortages in National Health Service trusts as part of their Workforce Plan for England publication. Staff shortages as defined by HEE may be filled by nurses working in agency, bank or overtime, however no estimate of the extent to which this occurs is available.</p><p> </p><p>HEE plan to publish the Workforce Plan for England 2017/18 in due course.</p> answering member printed Lord O'Shaughnessy question first answered 12/07/2017 13:50:07 answering member 4545 label Biography information for Lord O'Shaughnessy
tabling member	547 label Biography information for Lord Wigley

746106

registered interest
date	28/06/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
house id	2
legislature	25277 pref label House of Lords
question text	Her Majesty's Government how many mental health patients in England were sent away from their local area for treatment in each of the past three years for which figures are available.
tabling member printed	Lord Wigley
uin	HL248
answer	answer is ministerial correction date of answer 11/07/2017 answer text <p>The Out of Area Placement (OAP) definition was agreed in October 2016. The latest data published on OAPs covers the period from 17 October 2016 to 30 April 2017. During that time 4,153 OAPs have been recorded as starting in England.</p> answering member printed Lord O'Shaughnessy question first answered 11/07/2017 15:00:59 answering member 4545 label Biography information for Lord O'Shaughnessy
tabling member	547 label Biography information for Lord Wigley

733218

registered interest
date	27/06/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
house id	2
legislature	25277 pref label House of Lords
question text	Her Majesty's Government whether they will publish any assessment they have made regarding the extent of the improvement in clinical outcomes they expect would result from the proposed closure of congenital heart disease services at the Royal Brompton and Harefield NHS Foundation Trust.
tabling member printed	Lord Rennard
uin	HL210
answer	answer is ministerial correction date of answer 11/07/2017 answer text <p>No decision has been made regarding the congenital heart disease service at the Royal Brompton and Harefield NHS Foundation Trust.</p><p> </p><p>NHS England will make a decision on its proposals for changes to adult and children’s congenital heart services in England following consultation, which closes on 17 July 2017.</p><p> </p><p>The standards for congenital heart disease services were consulted upon and agreed by the board of NHS England in July 2015. The evidence base for the standards was published at the time and is available as part of the relevant board paper. The aim of these standards is to secure the best outcomes for all patients, including:</p><p> </p><p>- improved opportunities for survivors to lead better lives;</p><p>- tackling variation in services, particularly to ensure resilient 24-hour, seven days a week care; and</p><p>- improved patient experience.</p><p> </p><p>All of the standards, including those that refer to physical co-location of services, are based on expert clinical advice rather than published evidence, since research is not available to inform this aspect of service organisation.</p><p> </p> answering member printed Lord O'Shaughnessy grouped question UIN HL211 question first answered 11/07/2017 15:54:57 answering member 4545 label Biography information for Lord O'Shaughnessy
tabling member	2484 label Biography information for Lord Rennard

733219

registered interest
date	27/06/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
house id	2
legislature	25277 pref label House of Lords
question text	Her Majesty's Government whether they will publish any clinical evidence they have showing that the co-location of paediatric congenital heart surgery with other tertiary paediatric and supporting services is essential for better patient outcomes.
tabling member printed	Lord Rennard
uin	HL211
answer	answer is ministerial correction date of answer 11/07/2017 answer text <p>No decision has been made regarding the congenital heart disease service at the Royal Brompton and Harefield NHS Foundation Trust.</p><p> </p><p>NHS England will make a decision on its proposals for changes to adult and children’s congenital heart services in England following consultation, which closes on 17 July 2017.</p><p> </p><p>The standards for congenital heart disease services were consulted upon and agreed by the board of NHS England in July 2015. The evidence base for the standards was published at the time and is available as part of the relevant board paper. The aim of these standards is to secure the best outcomes for all patients, including:</p><p> </p><p>- improved opportunities for survivors to lead better lives;</p><p>- tackling variation in services, particularly to ensure resilient 24-hour, seven days a week care; and</p><p>- improved patient experience.</p><p> </p><p>All of the standards, including those that refer to physical co-location of services, are based on expert clinical advice rather than published evidence, since research is not available to inform this aspect of service organisation.</p><p> </p> answering member printed Lord O'Shaughnessy grouped question UIN HL210 question first answered 11/07/2017 15:54:57 answering member 4545 label Biography information for Lord O'Shaughnessy
tabling member	2484 label Biography information for Lord Rennard

732728

registered interest
date	26/06/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
house id	2
legislature	25277 pref label House of Lords
question text	Her Majesty's Government when they intend to publish the next Tobacco Control Plan for England; and whether that plan will include recommendations for the NHS as well as for local government.
tabling member printed	Baroness Finlay of Llandaff
uin	HL166
answer	answer is ministerial correction date of answer 06/07/2017 answer text <p>The Government is developing a new tobacco control plan, which will be published shortly.</p> answering member printed Lord O'Shaughnessy question first answered 06/07/2017 15:54:14 answering member 4545 label Biography information for Lord O'Shaughnessy
tabling member	3609 label Biography information for Baroness Finlay of Llandaff

732744

registered interest
date	26/06/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
house id	2
legislature	25277 pref label House of Lords
question text	Her Majesty's Government, further to the Written Answer by the Parliamentary Under-Secretary of State, Department of Health, on 24 April (HC70973), when and how the Commission on Human Medicines "thoroughly review the data" on human papilloma virus (HPV) vaccine adverse reactions.
tabling member printed	The Countess of Mar
uin	HL182
answer	answer is ministerial correction date of answer 04/07/2017 answer text <p>The Commission on Human Medicines (CHM) is the Government’s scientific advisory committee, from which the Medicines and Healthcare products Regulatory Agency (MHRA) seeks independent scientific advice.</p><p> </p><p>The CHM considered a thorough review of the safety of human papillomavirus (HPV) vaccine at its meeting on 16 July 2015. Prior to 2015, the CHM considered reviews of HPV vaccine at meetings in September 2012, September 2010, September 2009, June 2009 and February 2009. These reviews included evaluation of United Kingdom Yellow Card reports, analysis of data from the Clinical Practice Research Datalink (CPRD), published safety studies and safety data from other countries.</p><p>Most recently, the CHM considered the safety of HPV vaccine at its meeting on 15 October 2015. At this meeting, the MHRA sought advice from the CHM on the (Co)-Rapporteurs’ assessment reports prepared for the European Medicines Agency (EMA) review into reports of postural orthostatic tachycardia syndrome and complex regional pain syndrome following HPV vaccine, in order to inform the UK position in the review.</p><p><strong> </strong>As with all vaccines and medicines, the safety of HPV vaccine remains under continual review by the MHRA.</p> answering member printed Lord O'Shaughnessy question first answered 04/07/2017 16:04:46 answering member 4545 label Biography information for Lord O'Shaughnessy
tabling member	1861 label Biography information for The Countess of Mar

732745

registered interest
date	26/06/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
house id	2
legislature	25277 pref label House of Lords
question text	Her Majesty's Government whether, in the light of the significant increase in the number of cases of postural orthostatic tachycardia syndrome (POTS) reported as an adverse reaction to HPV vaccination since July 2015, they will ask the European Medicines Agency to review the safety signal.
tabling member printed	The Countess of Mar
uin	HL183
answer	answer is ministerial correction date of answer 03/07/2017 answer text <p>The European Medicines Agency (EMA) concluded a thorough review of reports of postural orthostatic tachycardia syndrome (POTS) following human papillomavirus (HPV) vaccine in November 2015, which found that the evidence did not support a causal association between HPV vaccination and POTS.</p><p> </p><p>As of 26 June 2017, the Medicines and Healthcare products Regulatory Agency (MHRA) has received 60 reports of POTS following HPV vaccine via the Yellow Card Scheme. More than three million girls have been vaccinated against HPV since 2008 across the United Kingdom, and the MHRA’s evaluation remains that the number of reports does not exceed what would be expected to occur in the absence of HPV vaccine and that the evidence does not suggest a causal association with the vaccine.</p><p> </p><p>The MHRA does not currently propose to ask the EMA to conduct a further review. As with the safety of all vaccines and medicines, this issue will remain under review.</p> answering member printed Lord O'Shaughnessy question first answered 03/07/2017 16:44:42 answering member 4545 label Biography information for Lord O'Shaughnessy
tabling member	1861 label Biography information for The Countess of Mar

732746

registered interest
date	26/06/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
house id	2
legislature	25277 pref label House of Lords
question text	Her Majesty's Government who advised the Commission on Human Medicines that the available evidence does not support a causal association between HPV vaccination and development of postural orthostatic tachycardia syndrome (POTS) or complex regional pain syndrome (CRPS) according to the Commission's minutes of 15–16 October 2015; and why this statement was made before the European Medicines Agency Scientific Advisory Group (SAG) reported on 21 October 2015.
tabling member printed	The Countess of Mar
uin	HL184
answer	answer is ministerial correction date of answer 04/07/2017 answer text <p>The Commission on Human Medicines (CHM) is the Government’s scientific advisory committee, from which the Medicines and Healthcare products Regulatory Agency (MHRA) seeks independent scientific advice.</p><p> </p><p>Following a review of human papillomavirus (HPV) vaccine safety on 16 July 2015, the CHM advised the MHRA that the available evidence does not support a causal association between HPV vaccination and development of postural orthostatic tachycardia syndrome (POTS) or complex regional pain syndrome (CRPS), as well as other chronic illnesses. The public minutes of this meeting were made available online on 18 November 2015.</p><p> </p><p>At its meeting on 15 October 2015, the MHRA sought advice from the CHM on the (Co)-Rapporteurs’ assessment reports prepared for the European Medicines Agency (EMA) review into reports of POTS and CRPS following HPV vaccine, in order to inform the United Kingdom position in the review. The public minutes of this meeting were made available online on 21 December 2015.</p><p> </p><p>The CHM did not make a statement in October in advance of the EMA’s Scientific Advisory Group meeting. The CHM’s minutes were published on the above dates in line with usual practice and have informed the MHRA’s responses to enquiries about the safety of HPV vaccine.</p> answering member printed Lord O'Shaughnessy question first answered 04/07/2017 16:05:33 answering member 4545 label Biography information for Lord O'Shaughnessy
tabling member	1861 label Biography information for The Countess of Mar

732747

registered interest
date	26/06/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
house id	2
legislature	25277 pref label House of Lords
question text	Her Majesty's Government what assessment they have made of the implications that the European Court of Justice's decision in Case C–621/15 will have for UK claims for vaccine damage.
tabling member printed	The Countess of Mar
uin	HL185
answer	answer is ministerial correction date of answer 06/07/2017 answer text <p>The European Court of Justice’s decision on this case does not impact on the United Kingdom. This case relates to specific circumstances and law in France.</p> answering member printed Lord O'Shaughnessy question first answered 06/07/2017 15:54:04 answering member 4545 label Biography information for Lord O'Shaughnessy
tabling member	1861 label Biography information for The Countess of Mar

732079

registered interest
date	22/06/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
house id	2
legislature	25277 pref label House of Lords
question text	Her Majesty's Government how many nursing posts were unfilled in NHS England on the most recent date for which figures are available; and what plans they have to fill those places.
tabling member printed	Lord Ouseley
uin	HL132
answer	answer is ministerial correction date of answer 05/07/2017 answer text <p>The information is not available in the format requested.</p><p> </p><p>Health Education England (HEE) provide estimates of staff shortages and the plan for tackling these issues as part of their Workforce Plan for England publication.</p><p> </p><p>HEE plan to publish the Workforce Plan for England 2017/18 in due course.</p> answering member printed Lord O'Shaughnessy question first answered 05/07/2017 14:28:05 answering member 4545 label Biography information for Lord O'Shaughnessy
tabling member	2170 label Biography information for Lord Ouseley